Targeted therapies: Cetuximab dosing by rash--is the scaling of EVEREST meaningful?
Sebastian
S
Stintzing
Heinz-Josef
HJ
Lenz
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000068818:Cetuximab; D004305:Dose-Response Relationship, Drug; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012871:Skin Diseases / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab